Additionally, S&P assigned its “A+” rating to Lucile Salter Packard Children’s Hospital’s $200 million series 2017A hospital revenue bonds.
“The rating change reflects a combination of factors which we believe make LPCH less flexible financially, particularly as the organization is gearing up to open and transition to a new hospital,” Suzie Desai, an S&P Global Ratings credit analyst, said.
The assignment is based on several factors, including the hospital’s strong market position, affiliation with Stanford University, healthy revenue base and solid unrestricted reserves. S&P also acknowledged the hospital’s increased capital spending and recently light operating income.
The outlook is stable.
More articles on healthcare finance:
Massena Memorial CFO blames employee insurance claims for net loss in June
HRSA awards WSU College of Nursing $1.3M to expand NP program
Montana health department proposes nearly 3.5% cut to Medicaid reimbursement
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit